Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Precision Medicine and Therapeutic Resistance
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response

DOI: 10.1158/2159-8290.CD-RW2021-031
  • Article
  • Info & Metrics
Loading
  • Major Finding: Double-strand breaks in mitochondrial DNA upregulated IFN signaling via cytosolic RNA sensing.

  • Concept: Mitochondrial DNA damage led to mitochondrial membrane herniation and release of mitochondrial RNA.

  • Impact: This work provides insight into the effects of mitochondrial DNA–damaging agents such as chemotherapy.


Embedded Image

Exposure to ionizing radiation and treatment with some chemotherapeutic agents can cause double-strand breaks (DSB) in mitochondrial DNA (mtDNA). To investigate the impact of mtDNA DSBs, Tigano and colleagues employed mtDNA-targeted transcription activator-like effector nucleases (TALEN), which are restriction enzymes engineered to cut DNA at specific sequences. In vitro, RNA-sequencing and RT-qPCR analyses showed that expression of the mtDNA-targeting TALENs caused changes in expression of nuclear genes, including several important IFN-stimulated genes. This was associated with a time-dependent increase in IFN-mediated phosphorylation of protein STAT1 at Y701, a modification required for STAT1 activation and consequent transcriptional induction of IFN-stimulated genes. This increase in phosphorylated STAT1 was not seen in cells lacking mtDNA, supporting the notion that the TALEN-induced mtDNA DSBs were the cause of the observed STAT1 activation in cells with normal mtDNA. Notably, the mtDNA DSBs did not appear to cause significant mitochondrial dysfunction; however, immunofluorescence microscopy analyses revealed herniation of the inner mitochondrial membrane triggered by the formation of BAX–BAK macropores, a process previously shown to expose mtDNA and mitochondrial RNA (mtRNA) to sensors in the cytoplasm. Further investigation showed that it was specifically the cytoplasmic mtRNA (and not mtDNA) that caused the immune response to mtDNA damage. The immunogenic effects of cytoplasmic mtRNA in cells with mtDNA damage was mediated by the RIG-I–MAVS pathway, in which the pattern recognition receptor RIG-I detects cytoplasmic RNA and then binds the signaling protein MAVS to activate a type I IFN response. Importantly, mtDNA damage was shown to underlie the innate immune response caused by exposure to ionizing radiation, which also exerted its effects via RIG-I–mediated mtRNA sensing. In summary, this work provides a detailed characterization of the immune effects of mtDNA DSBs in cells, offering insight into this effect of chemotherapy and irradiation.

Tigano M, Vargas DC, Tremblay-Belzile S, Fu Y, Sfeir A. Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance. Nature 2021 Feb 24 [Epub ahead of print].

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.

  • ©2021 American Association for Cancer Research.
PreviousNext
Back to top

This OnlineFirst version was published on March 5, 2021
doi: 10.1158/2159-8290.CD-RW2021-031

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response
Cancer Discov March 5 2021 DOI: 10.1158/2159-8290.CD-RW2021-031

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Mitochondrial DNA Damage Triggers an IFN-Mediated Immune Response
Cancer Discov March 5 2021 DOI: 10.1158/2159-8290.CD-RW2021-031
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Cell-Intrinsic Programs Partition Nutrients in Tumor Microenvironment
  • Extrachromosomal DNA Can Promote Oncogene Transcription in Trans
  • Transient Rest Reverses Exhaustion of Chimeric Antigen Receptor T Cells
Show more Research Watch
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement